Eris Lifesciences opened lower at ₹1,155.00, compared with its previous close of ₹1,157.10. During today's session, the stock has traded between ₹1,142.20 and ₹1,158.70, with an average traded price of ₹1,151.59. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Eris Lifesciences is now worth
₹ 14,476.00
giving a profit of
₹ 4,476.00 (44.76%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-7.30 (-0.63%)
Day High
₹1,158.70
Day Low
₹1,142.20
Day Open
₹1,155.00
Prev Close
₹1,157.10
Volume
41,111
Value Traded
₹4.73 Cr
1W Return
-3.26%
1M Return
-15.18%
3M Return
-19.66%
6M Return
-16.16%
1Y Return
-27.96%
Market Cap (₹ Cr.)
15,934
PE Ratio
24.10
PB Ratio
4.12
Dividend Yield
0.62%
ROE
16.62%
ROCE
15.72%
Book Value (₹)
281.30
Face Value (₹)
1.00
EPS (TTM)
10.28
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-3.26%
6 Week
-
1 Month
-15.18%
3 Month
-19.66%
9 Month
-23.05%
Eris Lifesciences accepts COO Krishnakumar Vaidyanathan's resignation
Krishnakumar Vaidyanathan resigned as Executive Director and COO of Eris Lifesciences Limited. Resignation effective from close of business hours on September 30, 2026. Board accepted resignation with waiver of applicable notice period. Vaidyanathan cited pursuit of professional opportunities outside the company.
8 days agoEris Lifesciences shareholders adopt FY26 financials, reappoint directors at AGM
Shareholders adopted FY26 audited financial statements with 99.997% support. Kaushal Kamlesh Shah reappointed as director with 99.26% votes in favour. Sujesh Vasudevan reappointed as Independent Director with 97.67% support. Cost auditor remuneration for FY27 ratified with 100% favourable votes.
18 days agoEris Lifesciences appoints Akhil Awasthi as additional director
Akhil Awasthi appointed as Additional Director (Non-executive, Independent). Effective date set for September 26, 2026, with a five-year term. Board approved the appointment on September 21, 2026. Role subject to final approval by company members.
22 days agoEris Lifesciences accepts resignation of Executive Director & COO
Krishnakumar Vaidyanathan resigns as Executive Director and COO. Resignation effective from close of business on September 30, 2026. Cited reason is pursuit of professional opportunities outside the firm. Filing made under Regulation 30 of SEBI LODR Regulations.
1mo agoEris Lifesciences secures ₹45 crore term loan from Axis Bank
Eris Lifesciences secured a ₹45 crore term loan from Axis Bank Limited. The funds are designated to meet other liabilities as per the agreement. The company stated the transaction will not impact expected net debt figures. Axis Bank holds a charge on the company's brands as security for the loan. Total outstanding term loans stand at ₹155.77 crore alongside ₹55 crore in working capital.
1mo agoEris Lifesciences hosts investor meet with Bank of India Mutual Fund
Eris Lifesciences holds investor meet on Sept 10, 2026. Bank of India Mutual Fund is the attending institutional investor. Krishnakumar Vaidyanathan represents management. Meeting is in-person and scheduled for 3:30 pm. Disclosed under SEBI LODR Regulation 30.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Eris Lifesciences is now worth
₹ 14,476.00
giving a profit of
₹ 4,476.00 (44.76%)
Note: Past profits do not guarantee future returns.
